Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19. - Weiss LJ; Drayss M; Manukjan G; Zeitlhöfler M; Kleiss J; Weigel M; Herrmann J; Mott K; Beck S; Burkard P; Lâm TT; Althaus K; et al. (Blood advances, 2023)